Non-Current Assets
Strategic investments
Pfizer Strategic investments increased by 0.3% to $1.63B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.1%, from $1.79B to $1.63B. Over 5 years (FY 2020 to FY 2025), Strategic investments shows a downward trend with a -13.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase reflects long-term capital deployment or strategic acquisitions, while a decrease may indicate the sale of non-core assets.
Detailed definition
This category includes long-term financial assets, such as strategic investments in other companies or long-term securit...
Peer comparison
Found in most large-cap companies; reflects the firm's strategy for non-core asset management.
Metric ID:
non_current_assets_other_long_term_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.33B | $5.25B | $5.05B | $4.74B | $4.16B | $4.06B | $4.04B | $3.57B | $3.64B | $3.21B | $3.73B | $3.49B | $3.12B | $2.18B | $2.23B | $1.79B | $1.90B | $2.14B | $1.62B | $1.63B |
| QoQ Change | — | +21.1% | -3.7% | -6.2% | -12.2% | -2.4% | -0.6% | -11.6% | +2.1% | -11.8% | +16.1% | -6.5% | -10.6% | -30.1% | +2.2% | -19.7% | +6.0% | +12.7% | -24.1% | +0.3% |
| YoY Change | — | — | — | — | -3.9% | -22.6% | -20.1% | -24.8% | -12.5% | -20.9% | -7.6% | -2.2% | -14.4% | -32.2% | -40.3% | -48.7% | -39.2% | -2.0% | -27.2% | -9.1% |
Range$1.62B – $5.25B
CAGR-18.6%
Avg YoY Growth-20.5%
Median YoY Growth-20.5%
Strategic investments at Other Companies
Frequently Asked Questions
- What is Pfizer's strategic investments?
- Pfizer (PFE) reported strategic investments of $1.63B in Q1 2026.
- How has Pfizer's strategic investments changed year-over-year?
- Pfizer's strategic investments decreased by 9.1% year-over-year, from $1.79B to $1.63B.
- What is the long-term trend for Pfizer's strategic investments?
- Over 5 years (2020 to 2025), Pfizer's strategic investments has grown at a -13.8% compound annual growth rate (CAGR), from $3.41B to $1.62B.
- What does strategic investments mean?
- Long-term investments held for strategic purposes rather than immediate operational use.